Showing results (311-320 of 390) with videos related to

Sort By:
Pageof 39
Journal of Nanoscience and Nanotechnology|November 18, 2009
Characterization of carbon nanofibers grown over Ni and Ni-cu catalystsY Echegoyen, I Suelves, M J Lázaro, et al.
European Journal of Clinical Pharmacology|November 16, 1978
Digoxin, whole body potassium and the electrocardiogramP H Joubert, F O Müller, F W van Rijssen, et al.
Neuroimage|August 16, 2012
Direct visualization of cerebellar nuclei in patients with focal cerebellar lesions and its application for lesion-symptom mappingS Maderwald, M Thürling, M Küper, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1992
The effects of felodipine on the pharmacokinetics of diazepamB H Meyer, F O Müller, H K Hundt, et al.
Molecular Genetics and Genomics : MGG|December 4, 2004
A H2O2-producing glyoxal oxidase is required for filamentous growth and pathogenicity in Ustilago maydisB Leuthner, C Aichinger, E Oehmen, et al.
Carbohydrate Polymers|February 13, 2013
Mixture design applied for the study of the tartaric acid effect on starch/polyester filmsJ B Olivato, M M Nobrega, C M O Müller, et al.
Nature Genetics|January 13, 1998
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinaseD E Jenne, H Reimann, J Nezu, et al.
Arzneimittel-Forschung|October 1, 1989
Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and manH J Ahr, M Boberg, H P Krause, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
Scientific Reports|September 3, 2020
Aggravation of symptom severity in adult attention-deficit/hyperactivity disorder by latent Toxoplasma gondii infection: a case-control studyAlexandra P Lam, Dominik de Sordi, Helge H O Müller, et al.
Pageof 39